Evidence map›Paper›PMID 35063704›Full record

ArticleNeoplasia (New York, N.Y.)2022

Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis.

Parag P Shah, Kumar Saurabh, Zimple Kurlawala, Alexis A Vega, Leah J Siskind, Levi J Beverly

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Parag P ShahJames Graham Brown Cancer Center, University of Louisville, 505 S. Hancock Street, CTRB rm 204, Louisville, KY 40202, USA.
Kumar SaurabhJames Graham Brown Cancer Center, University of Louisville, 505 S. Hancock Street, CTRB rm 204, Louisville, KY 40202, USA.
Zimple KurlawalaJames Graham Brown Cancer Center, University of Louisville, 505 S. Hancock Street, CTRB rm 204, Louisville, KY 40202, USA.
Alexis A VegaDepartment of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40202, USA.
Leah J SiskindJames Graham Brown Cancer Center, University of Louisville, 505 S. Hancock Street, CTRB rm 204, Louisville, KY 40202, USA; Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Levi J BeverlyJames Graham Brown Cancer Center, University of Louisville, 505 S. Hancock Street, CTRB rm 204, Louisville, KY 40202, USA; Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY 40202, USA; Department of Medicine, Division of Hematology and Oncology, University of Louisville School of Medicine, Louisville, KY 40202, USA; Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA. Electronic address: Levi.Beverly@Louisville.edu.
University of Louisville · US

Funding

WKU Lead Faculty AwardP20GM103436 · NIGMS · UNIVERSITY OF LOUISVILLE · PI ERIC C ROUCHKA · 2012 to 2026
$60.1M
Ubiquilins regulate EMT, migration and invasion of human lung cancerR01CA193220 · NCI · UNIVERSITY OF LOUISVILLE · PI BEVERLY, LEVI J · 2015 to 2019
$2.3M
NCI NIH HHS R01 CA193220NIGMS NIH HHS P20 GM103436
6 · The paper itself

Abstract

The Ubiquilin family of proteins (UBQLN) consists of five related proteins (UBQLN1-4 and UBQLNL) that all contain ubiquitin-like (UBL) and ubiquitin-associated (UBA) domains. UBQLN1 and UBQLN2 are the most closely related and have been the most well-studied, however their biochemical, biological and cellular functions are still not well understood. Previous studies from our lab reported that loss of UBQLN1 or UBQLN2 induces epithelial mesenchymal transition (EMT) in lung adenocarcinoma cells. Herein, we showed that loss of UBQLN1 and/or UBQLN2 induces cellular processes involved in tumor progression and metastasis, including proliferation, clonogenic potential and migration in lung adenocarcinoma cells. In fact, following simultaneous loss of both UBQLN1 and UBQLN2 many of these processes were further enhanced. To understand the molecular mechanisms by which UBQLN1 and UBQLN2 loss could be additive, we performed molecular, biochemical and RNAseq analyses in multiple cellular systems. We identified overlapping and distinct gene sets and pathways that were altered following loss of UBQLN1 and/or UBQLN2. We have also begun to define cell type specific gene regulation of UBQLN1 and UBQLN2, as well as understand how loss of either gene can alter differentiation of normal cells. The data presented here demonstrate that UBQLN1 and UBQLN2 perform similar, but distinct molecular functions in a variety of cell types.

Indexed as

Adenocarcinoma of LungLung NeoplasmsAdaptor Proteins, Signal TransducingAutophagy-Related ProteinsCell Cycle ProteinsHumansUbiquitinAdaptor Proteins, Signal TransducingAutophagy-Related ProteinsCell Cycle ProteinsUbiquitinUBQLN1 protein, humanUBQLN2 protein, humanEMTERADMetastasisRNAseqUBQLN1UBQLN2

Identifiers

PMID35063704
PMCPMC8864381
OpenAlexW4206109482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.